183 related articles for article (PubMed ID: 22664782)
1. Differences in microparticle release in patients with acute coronary syndrome and stable angina.
Biasucci LM; Porto I; Di Vito L; De Maria GL; Leone AM; Tinelli G; Tritarelli A; Di Rocco G; Snider F; Capogrossi MC; Crea F
Circ J; 2012; 76(9):2174-82. PubMed ID: 22664782
[TBL] [Abstract][Full Text] [Related]
2. Persistent circulating platelet and endothelial derived microparticle signature may explain on-going pro-thrombogenicity after acute coronary syndrome.
Koganti S; Eleftheriou D; Gurung R; Hong Y; Brogan P; Rakhit RD
Thromb Res; 2021 Oct; 206():60-65. PubMed ID: 34418680
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-derived microparticles are released into the coronary circulation following percutaneous coronary intervention in acute coronary syndrome patients.
Martínez GJ; Barraclough JY; Nakhla S; Kienzle V; Robertson S; Mallat Z; Celermajer DS; Patel S
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27913753
[TBL] [Abstract][Full Text] [Related]
4. Microparticles in acute coronary syndrome.
Mavroudis CA; Eleftheriou D; Hong Y; Majumder B; Koganti S; Sapsford R; North J; Lowdell M; Klein N; Brogan P; Rakhit RD
Thromb Res; 2017 Aug; 156():109-116. PubMed ID: 28624718
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of circulating endothelial and platelet microparticles in men with ankylosing spondylitis.
Sari I; Bozkaya G; Kirbiyik H; Alacacioglu A; Ates H; Sop G; Can G; Taylan A; Piskin O; Yildiz Y; Akkoc N
J Rheumatol; 2012 Mar; 39(3):594-9. PubMed ID: 22247348
[TBL] [Abstract][Full Text] [Related]
6. Circulating microparticles in patients with coronary heart disease and its correlation with interleukin-6 and C-reactive protein.
Cui Y; Zheng L; Jiang M; Jia R; Zhang X; Quan Q; Du G; Shen D; Zhao X; Sun W; Xu H; Huang L
Mol Biol Rep; 2013 Nov; 40(11):6437-42. PubMed ID: 24078095
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
[TBL] [Abstract][Full Text] [Related]
8. Negative Association of Circulating MicroRNA-126 with High-sensitive C-reactive Protein and Vascular Cell Adhesion Molecule-1 in Patients with Coronary Artery Disease Following Percutaneous Coronary Intervention.
Wang JN; Yan YY; Guo ZY; Jiang YJ; Liu LL; Liu B
Chin Med J (Engl); 2016 Dec; 129(23):2786-2791. PubMed ID: 27900989
[TBL] [Abstract][Full Text] [Related]
9. OX40 ligand levels and high-sensitivity C-reactive protein levels in blood from local coronary plaque and the femoral artery in patients with acute coronary syndrome or stable angina.
Shi JZ; Wang LY; Zhu Y; Zhao CY; Liu W; Jiang SL; You HW; Wang Y; Xu FY; Tang YS; Cui LQ
J Int Med Res; 2011; 39(4):1275-83. PubMed ID: 21986129
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress.
Helal O; Defoort C; Robert S; Marin C; Lesavre N; Lopez-Miranda J; Risérus U; Basu S; Lovegrove J; McMonagle J; Roche HM; Dignat-George F; Lairon D
Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):665-71. PubMed ID: 20399083
[TBL] [Abstract][Full Text] [Related]
11. Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention.
Porto I; Biasucci LM; De Maria GL; Leone AM; Niccoli G; Burzotta F; Trani C; Tritarelli A; Vergallo R; Liuzzo G; Crea F
Eur Heart J; 2012 Dec; 33(23):2928-38. PubMed ID: 22453653
[TBL] [Abstract][Full Text] [Related]
12. Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction.
Jung C; Sörensson P; Saleh N; Arheden H; Rydén L; Pernow J
Atherosclerosis; 2012 Mar; 221(1):226-31. PubMed ID: 22245039
[TBL] [Abstract][Full Text] [Related]
13. [Tissue factor expression of platelets and leukocytes in patients with acute coronary syndromes].
Lu HY; Chen D; Gu J; Song LX; Chen M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):678-83. PubMed ID: 23815921
[TBL] [Abstract][Full Text] [Related]
14.
Nijiati M; Saidaming A; Guoqing L
Ann Clin Lab Sci; 2017 Mar; 47(2):156-161. PubMed ID: 28442516
[TBL] [Abstract][Full Text] [Related]
15. Higher Plasma Concentrations of Platelet Microparticles in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysis.
Sun C; Zhao WB; Chen Y; Hu HY
Can J Cardiol; 2016 Nov; 32(11):1325.e1-1325.e10. PubMed ID: 27177836
[TBL] [Abstract][Full Text] [Related]
16. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
Christersson C; Thulin Å; Siegbahn A
Thromb Haemost; 2017 Jul; 117(8):1571-1581. PubMed ID: 28424820
[TBL] [Abstract][Full Text] [Related]
17. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography.
Kobayashi N; Takano M; Hata N; Kume N; Yamamoto M; Yokoyama S; Shinada T; Tomita K; Shirakabe A; Otsuka T; Seino Y; Mizuno K
Int J Cardiol; 2013 Oct; 168(4):3217-23. PubMed ID: 23632121
[TBL] [Abstract][Full Text] [Related]
18. Gender-specific and menstrual cycle dependent differences in circulating microparticles.
Toth B; Nikolajek K; Rank A; Nieuwland R; Lohse P; Pihusch V; Friese K; Thaler CJ
Platelets; 2007 Nov; 18(7):515-21. PubMed ID: 17957567
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived microparticles during and after acute coronary syndrome.
Skeppholm M; Mobarrez F; Malmqvist K; Wallén H
Thromb Haemost; 2012 Jun; 107(6):1122-9. PubMed ID: 22371053
[TBL] [Abstract][Full Text] [Related]
20. Different characteristics of cardiac biomarkers to decide and predict the culprit lesions in patients with suspicious acute coronary syndrome.
Kitamura M; Hata N; Takayama T; Hirayama A; Ogawa M; Yamashina A; Mera H; Yoshino H; Nakamura F; Seino Y
Heart Vessels; 2016 Jun; 31(6):907-17. PubMed ID: 26081026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
